Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Evaluating vascular aging after COVID-19 infection

Official title: Covid-19 Effects on ARTErial StIffness and Vascular AgiNg

Run by Assistance Publique - Hôpitaux de Paris · NCT04558450 · Data updated 2026-11-12

This study is testing how COVID-19 affects blood vessel health and aging in adults by checking their heart and blood vessel function six and twelve months after infection.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment360 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations3 sites (Nancy and 2 other locations)
StatusRecruiting
StartedSeptember 21, 2020
Main results expectedMarch 2023
Study endsMarch 2033
Registry record updatedNovember 22, 2021
Trial IDNCT04558450 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 years old who have recently been diagnosed with COVID-19 and have varying hospitalization experiences.

Probably not a fit

Patients under 18 years old, those unable to provide consent, or with life-limiting conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the effects of COVID-19 on arterial stiffness and vascular aging by conducting non-invasive evaluations of vascular and cardiac function in patients six and twelve months post-infection. Eligible participants will include adults diagnosed with COVID-19, with varying degrees of hospitalization, and will undergo assessments to measure carotid-femoral pulse-wave velocity. Additionally, cardiovascular events and mortality data will be collected over a period of 10 years to understand long-term impacts.

Why it matters

Potential benefit: If successful, this study could provide insights into the long-term cardiovascular effects of COVID-19, potentially leading to improved management and treatment strategies for affected patients.

How similar studies have gone: Other studies have explored the cardiovascular effects of COVID-19, indicating a growing body of evidence, but this specific approach to vascular aging is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age \>18 years, both sexes;
* written informed consent;
* affiliation to a social security regime;
* a recent diagnosis of COVID19 (6±3 months) proven by PCR or serology (for group 1,2,3)
* hospitalization in intensive care unit for COVID19 (for group 1)
* hospitalization in a medicine unit for COVID19 (for group 2)
* no hospitalization for COVID19 or hospitalization less than 24h (for group 3)
* a negative test for SARS-nCOV2 infection (PCR or serology)(for group 4)

Exclusion Criteria:

* Age \<18 years
* Inability to express consent of the study
* Diseases carrying out a life -expectancy \<1 year according to clinical judgment
* Pregnancy and breastfeeding
* Foreseen inability to attend scheduled visits

Where it's running

  • CHRU Nancy
    Nancy, France
    Recruiting
  • Hôpital Européen Georges Pompidou - APHP
    Paris, France
    Recruiting
  • CHU Rouen
    Rouen, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.